This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 116 of Patent CN110785183A
General Information
DRACP ID DRACP06399
Peptide Name SEQ ID NO: 116 of Patent CN110785183A
Sequence VLMEENSKL
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-A*02
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C45H79N11O16S
Absent amino acids ACDFGHIPQRTWY
Common amino acids EL
Mass 120512
Pl 4.26
Basic residues 1
Acidic residues 2
Hydrophobic residues 3
Net charge -1
Boman Index -1298
Hydrophobicity -16.67
Aliphatic Index 118.89
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.